Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 438 Breast Neoplasms 383 Neoplasms 292 Prostatic Neoplasms 196 Neoplasm Metastasis 156 Multiple Myeloma 148 Colorectal Neoplasms 124 Lung Neoplasms 105 Ovarian Neoplasms 102 Parkinson Disease 4, Autosomal Dominant Lewy Body 98 Melanoma 95 Lymphoma, Follicular 94 Recurrence 88 Lymphoma, Non-Hodgkin 82 Papillomavirus Infections 81 Leukemia, Lymphocytic, Chronic, B-Cell 81 Carcinoma, Hepatocellular 81 Stomach Neoplasms 76 Small Cell Lung Carcinoma 73 Leukemia, Myeloid, Acute 70 Pancreatic Neoplasms 67 Pain 66 Carcinoma, Renal Cell 65 Uterine Cervical Neoplasms 64 Keratosis, Actinic 63 Urinary Bladder Neoplasms 59 Myasthenia Gravis 53 Lymphoma, Large B-Cell, Diffuse 53 Leiomyoma 49 Carcinoma 49

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Non Squamous Lung Cancer × Clear all

NCT01154140 2017-11-06

PROFILE 1014

Pfizer

Phase 3 Completed

343 enrolled 31 charts

Non Squamous Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡